BerGenBio ASA (OSL: BGBIO)
Norway
· Delayed Price · Currency is NOK 8.56
+0.07 (0.79%)
Jan 17, 2025, 4:25 PM CET
BerGenBio ASA Revenue
BerGenBio ASA had revenue of 521.00K NOK in the twelve months ending September 30, 2024, up 33.93% year-over-year. In the year 2023, BerGenBio ASA had annual revenue of 354.00K, down -9.00%.
Revenue (ttm)
521.00K
Revenue Growth
+33.93%
P/S Ratio
n/a
Revenue / Employee
34.73K
Employees
16
Market Cap
329.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 354.00K | -35.00K | -9.00% |
| Dec 31, 2022 | 389.00K | -385.00K | -49.74% |
| Dec 31, 2021 | 774.00K | 173.00K | 28.79% |
| Dec 31, 2020 | 601.00K | -8.30M | -93.25% |
| Dec 31, 2019 | 8.90M | 6.57M | 281.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nordhealth AS | 513.12M |
| Medistim ASA | 541.82M |
| Photocure ASA | 526.25M |
| Hofseth BioCare ASA | 248.08M |
| Vistin Pharma ASA | 426.52M |
| Nykode Therapeutics AS | 46.02M |
| Omda AS | 419.59M |
| ArcticZymes Technologies ASA | 110.76M |